Tag: Pradaxa

October 16, 2015 Off

FDA approved Praxbind for patients taking Pradaxa

By Dino Mustafić

The U.S. Food and Drug Administration on Friday granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.